Ronald Buggage

Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

Frédéric Lallemand, Philippe Daull, Simon Benita et al. · Journal of Drug Delivery · 2012 · 305 citations · Full text

Nanomedicine, Medicinal Chemistry, Vitreous Body +15

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Jeffrey S. Heier, Saleema Kherani, Shilpa J. Desai et al. · The Lancet · 2017 · 220 citations

Open-label Trial, Translational Medicine, Ocular Disease +8

Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious UveitisA Multicenter Noncomparative Interventional Case Series

Robert B. Nussenblatt, Jerry A. Peterson, C. Stephen Foster et al. · Ophthalmology · 2005 · 135 citations

Initial Evaluation, Subcutaneous Daclizumab Treatments, Treatment Option +4

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial

Lawrence J. Singerman, Harvey Masonson, M. Patel et al. · British Journal of Ophthalmology · 2008 · 130 citations · Full text

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Robert B. Nussenblatt, Darby J. S. Thompson, Zhuqing Li et al. · Journal of Autoimmunity · 2003 · 119 citations

Inflammation, Uveitis Patients, Medicine +8